Remed Co.Ltd
Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells,… Read more
Remed Co.Ltd (302550) - Total Assets
Latest total assets as of September 2025: ₩55.32 Billion KRW
Based on the latest financial reports, Remed Co.Ltd (302550) holds total assets worth ₩55.32 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Remed Co.Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Remed Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Remed Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Remed Co.Ltd's total assets of ₩55.32 Billion consist of 48.5% current assets and 51.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩2.41 Billion | 0.0% |
| Accounts Receivable | ₩6.87 Billion | 11.6% |
| Inventory | ₩6.64 Billion | 11.2% |
| Property, Plant & Equipment | ₩22.58 Billion | 38.2% |
| Intangible Assets | ₩165.67 Million | 0.3% |
| Goodwill | ₩1.47 Billion | 2.5% |
Asset Composition Trend (2017–2024)
This chart illustrates how Remed Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Remed Co.Ltd's current assets represent 48.5% of total assets in 2024, an increase from 42.0% in 2017.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, the same as 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 38.2% of total assets.
Remed Co.Ltd Competitors by Total Assets
Key competitors of Remed Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Remed Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Remed Co.Ltd generates 0.43x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Remed Co.Ltd generates $ 12.14 in net profit.
Remed Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.93 | 1.82 | 10.42 |
| Quick Ratio | 2.13 | 1.44 | 9.67 |
| Cash Ratio | 0.00 | 0.13 | 0.00 |
| Working Capital | ₩19.84 Billion | ₩ 14.58 Billion | ₩ 42.25 Billion |
Remed Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Remed Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.42 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.3% |
| Total Assets | ₩59.06 Billion |
| Market Capitalization | $43.44 Million USD |
Valuation Analysis
Below Book Valuation: The market values Remed Co.Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Remed Co.Ltd's assets grew by 7.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Remed Co.Ltd (2017–2024)
The table below shows the annual total assets of Remed Co.Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩59.06 Billion | +7.27% |
| 2023-12-31 | ₩55.06 Billion | -29.52% |
| 2022-12-31 | ₩78.13 Billion | +1.20% |
| 2021-12-31 | ₩77.20 Billion | +5.08% |
| 2020-12-31 | ₩73.47 Billion | +110.23% |
| 2019-12-31 | ₩34.95 Billion | +62.45% |
| 2018-12-31 | ₩21.51 Billion | +70.81% |
| 2017-12-31 | ₩12.59 Billion | -- |